@FiercePharma: AZ's Onglyza has most to lose at FDA safety confab, analysts say. Story | Follow @FiercePharma
@EricPFierce: Supply chain slip results in expired #Pfizer birth control pills being sold in Canada. More | Follow @EricPFierce
@CarlyHFierce: Mid-cap biotech beats most of the big dogs with 21.9% revenue growth. Article | Follow @CarlyHFierce
> AbbVie ($ABBV) and its fellow defendants asked a judge to bar the Federal Trade Commission from using studies about the pharmaceutical industry in an upcoming pay-for-delay trial over AndroGel. Report (reg. req.)
> Former FDA Commissioner Margaret Hamburg has joined the Institute of Medicine as a senior adviser focused on international matters. Report
> A Georgia federal judge ordered prosecutors to add details to an indictment accusing an accountant of insider trading related to a $1.9 billion Sanofi ($SNY) acquisition. Report (reg. req.)
> Pharmacy chain Walgreens Boots Alliance ($WBA) expanded its restructuring program with plans to close 200 U.S. stores. Report (sub. req.)
> Four Indian pharma companies saw their shares fall after Bank of America Merrill Lynch issued a downgrade. Report
Medical Device News
@FierceMedDev: France's Labco tiptoes closer to IPO. FierceDiagnostics article | Follow @FierceMedDev
@VarunSaxena2: ICYMI from FierceDiagnostics: Alere earns FDA clearance for rapid diagnostic of Strep A. News | Follow @VarunSaxena2
@EmilyWFierce: Roche nabs EU approval for Avastin for cervical cancer. Report from FiercePharma | Follow @EmilyWFierce
> Aethlon Medical eyes full marketing approval for Ebola biofiltration device. Story
> Synaptive's 'GPS for the brain' gets FDA green light. Article
Biotech News
@FierceBiotech: One of Shire's top blockbuster drug prospects flops in a key PhII study. News | Follow @FierceBiotech
@JohnCFierce: What bubble? Woodford boosts biotech fund max to $1.2B as investors crowd in. More | Follow @JohnCFierce
@DamianFierce: ICYMI: The thrilling conclusion to #FierceMadness and why I've had "One Shining Moment" stuck in my head all day. Story | Follow @DamianFierce
> Edge Therapeutics hauls in $72.5M for brain injury R&D. More
> Prothena files for follow-on offering to build $400M R&D war chest. News
CRO News
> WuXi gets a manufacturing subsidiary on the Chinese stock market. Report
> Parexel partners up for clinical trial education. News
> Catalent reaches into Australia with latest buyout. More
> PPD sets off in Japan with SNBL joint venture. Story
> AMRI shutters another plant with an eye on its bottom line. Article
Vaccines News
> GSK relocates vaccine R&D to Maryland with new global center. Story
> Sanofi teams up with VBI Vaccines to improve vaccine stability. News
> Duke University scores $20M from NIH to develop HIV vaccine. Report
> Sanofi 'flipping the model' for high-stakes dengue rollout. More
> Northwest Bio gets $40M more for controversial brain cancer vaccine. Article
Pharma Manufacturing News
> Report: Supply chain efficiency can boost both top- and bottom-line results. Story
> Cipla buying Brazilian distributor for beachhead there. News
> Expired Pfizer contraceptives recalled after supply chain fumble. Report
> Indonesia market expanding but local producers can't keep up. Article
> Chinese drugmaker to build $60M API plant. Story
Pharma Asia News
> Japan, S. Korea hospitals ink clinical pact on regenerative medicine. News
> China's Sihuan marks first U.S. patient enrollment of PhI oncology candidate. Item
> India drug price chief sacked as essential drug prices rise. Article
> U.S. unit of Glenmark settles Medicaid charges for $25M. Story
> Asian device market set to leap to $15B in 2017. Report
And Finally... After a measles outbreak in California, state lawmakers have advanced a bill eliminating parental waivers exempting kids from vaccination. Report (sub. req.)